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Abstract
The drug abuse known to occur during growth of animals intended for food 
production, because of their use as either a prophylactic or therapeutic treatment, 
promotes the emergence of bacterial drug resistance. It has been reported that at 
least 25% of the foodborne isolates show drug resistance to one or more classes 
of antimicrobials (FAO 2018). There are diverse mechanisms that promote drug 
resistance. It is known that the use of sub-therapeutic doses of antibiotics in animals 
intended for food production promotes mutations of some chromosomal genes 
such as gyrA-parC and mphA, which are responsible for quinolone and azithro-
mycin resistance, respectively. Also, the horizontal transfer of resistance genes as 
groups (“cassettes”) or plasmids makes the spread of resistance to different bacte-
rial genera possible, among which there could be pathogens. The World Health 
Organization considers the emergence of multidrug-resistant pathogenic bacteria as 
a health problem, since the illnesses caused by them complicate the treatment and 
increase the morbidity and mortality rates. The complication in the illness treat-
ment caused by a multidrug-resistant pathogen causes economic losses to patients 
for the payment of long stays in hospitals and also causes economic losses to compa-
nies due to the absenteeism of their workers.
Keywords: multidrug-resistant bacteria, MDR, foodborne pathogens, antimicrobial 
resistance, MDR bacteria human health, MDR microorganism economic impact
1. Introduction
Increasing antimicrobial resistance (AMR) is a global public health threat. The 
excessive use and abuse of drug therapies in humans and in the animals intended 
for human consumption, and its bad disposition as a waste, have tightened up the 
problem in recent years [1]. This phenomenon affects any person regardless of sex, 
age, origin, or social status and threats the ability to effectively solve the treatments 
of different diseases and also compromises the food security, economy, and devel-
opment of the countries [2].
Microorganisms are sensitive to antimicrobials when they do not harbor com-
ponents involved in degrading them. AMR occurs when bacteria, fungi, viruses, 
and parasites are exposed for a long time to sub-therapeutic doses of drugs such 
as antibiotics, antifungals, antivirals, antimalarials, or anthelmintics that modify 
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the ecology of microorganism. In order to contend with the residues present in 
their environment, microorganisms may acquire genetic elements that allow them 
to cope with these compounds and survive. In some cases, the use of poor quality 
drug, counterfeit products, incorrect product, and modified dosage can accelerate 
the development of microbial resistance. Another relevant factor for development 
of AMR is the inadequate disposal of waste generated in the agricultural production 
and pharmaceutical and wastewater treatment plants as they can be spread through 
the environment [3]. One of the recently described phenomena observed is the 
association between the emergence of multiresistant microorganisms (MMR) and 
the increase in the isolates that show the production of extended-spectrum beta-
lactamase enzymes (ESBL). Currently, more than 200 varieties of BLEE enzymes 
are recognized with different substrates, and the frequency of isolates producing 
these enzymes varies from country to country (from 20 to 48%) [3].
Although there are many factors that favor the spread of antibiotic resistance, it 
affects different sectors, such as human health, animal health, agriculture, environ-
ment, and commercial trade [4]. It is estimated that 700,000 people die each year 
from infections caused by microorganisms resistant to antimicrobials and a large 
number of sick animals that do not respond to treatments [5]. Within the agricul-
tural and food industry, resistant microorganisms represent a risk for production 
that threatens the global economy. For this reason, it is important to implement 
supervised agricultural regulations and practices that ensure the responsible use of 
antimicrobials in the production of animals and crops.
2. Mechanisms and propagation of resistance
In microorganisms, drug resistance arises in order to contend against a harmful 
stimulus that threatens their survival. In bacteria, the mechanisms that confer the 
resistance against antibiotics could be classified as intrinsic (mutations originating 
in the organism itself) or acquired by transfer of genetics elements during the rep-
lication of DNA (vertical transfer) or from different species or genera (horizontal 
transfer) [6] (Figure 1).
2.1 Intrinsic mechanisms or natural resistance
The intrinsic mechanisms can be found in the cell in a natural manner. They are 
conditions that are universally found in bacterial species and that are independent 
of antibiotic selectivity [7]. Some of the intrinsic mechanisms are described below.
2.1.1 Permeability or impermeability of the outer membrane or cell wall
Gram-positive bacteria are more susceptible to various antibiotics since they have 
a thick outer layer of peptidoglycan with polymers of teichoic acid and covalently 
bound proteins, which allows the easy penetration of small molecules up to 30–57 kDa 
[8, 9]. In contrast, Gram-negative bacteria have an outer membrane that surrounds 
them with a relatively thin peptidoglycan layer. The composition of the outer mem-
brane is based on lipid molecules covalently linked to polysaccharide units [10].
The lipid molecule has a large chain of fatty acids that contribute to reduce the 
fluidity of the lipopolysaccharide (LPS) membrane [10]. The central region of the 
LPS plays an important role providing a barrier to hydrophobic antibiotics and 
other compounds. It has been reported that strains that express full-length LPS have 
an intrinsic resistance to hydrophobic antibiotic class such as macrolides and ami-
noglycosides. Another modification observed is the alteration of the anionic nature 
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of the LPS; the most common LPS modifications are the cationic substitution of 
phosphate groups with 4-amino-4-deoxy-L-arabinose (L-Ara4N) or phosphoetha-
nolamine (PEtN), which decreases the net negative load of lipid A from minus 1.5 
to minus 1 or from minus 1.5 to 0, respectively [11]. The net positive charge result-
ing from the LPS modification reduces the binding of some cationic antibiotics 
such as polymyxins, leading the resistance of the bacteria such as Escherichia coli, 
Klebsiella pneumoniae, and Salmonella enterica [12].
Figure 1. 
Schematic representation of the mechanisms of multidrug-resistance acquisition in bacteria.
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On the other hand, embedded in the outer layer membrane of Gram-negative 
bacteria, there are proteins called porins that function as a channel through which 
the molecules can diffuse. Porins could restrict the influx of numerous antibiotics 
and contribute to the resistance against them [13]. The mechanism of resistance 
promoted by the porins consists in changing the hydrophilic composition of some 
antibiotics such as beta-lactam, chloramphenicol, fluoroquinolones, and tetracy-
clines. Likewise, the alteration of the amount or modification of the structure of the 
porins promotes resistance to antibiotics [11].
2.1.2 Expulsion of the antibiotic by active mechanisms
In general those mechanisms are mediated by bacterial flow pumps that actively 
transport many toxic molecules out of the cell [14]. The outflow pumps can interact 
with only one molecule (enzyme substrate specific), or they can have a broader 
spectrum and export distinct classes of molecules. Antibiotic resistance mediated 
by active outflow pumps may be incidental, since the pumps exhibit a broad-range 
substrate [9]. However, efflux pumps associated with antibiotic resistance have 
been described in Gram-positive and Gram-negative bacterial pathogens. The 
energy of some flow pumps depends of the antibiotic agents in order to extract 
it from the periplasm to the outside. The overexpression of one or more of these 
flow pumps prevents the intracellular accumulation of antibiotics at the thresholds 
necessary to exert their inhibitory activity [15].
2.1.3 Modification of the target site
Most of the antibiotics bind specifically to their targets with high affinity. 
Changes in target structure prevent an effective binding to antibiotics but still 
allow the target to carry out its normal function. The target modification could be 
originated by a mutation in the gene that encodes for the antibiotic target [14]. An 
example of this mutation mechanism is the linezolid antibiotic, a member of the 
oxazolidinone class, which inhibits the initiation of bacterial translation by altering 
multiple copies of the V domain of the 23S rRNA in Gram-positive bacteria. The 
mutation in one of these copies of the V domain can confer antibiotic resistance [16].
Another mechanism relies in avoiding or releasing the binding of the antibiotic 
to their target site [17]. One of the most representative examples of this mechanism 
and of current importance is that used by quinolones, which exert their function 
by inhibiting important enzymes of bacterial DNA replication such as gyrase and 
topoisomerases II and IV. The mechanism of evasion of the antibiotic function is by 
the expression of repeating pentapeptides (PRP), encoded by qrn genes, which bind 
and promote the release of the quinolone from the target enzymes, allowing the 
normal activity of the topoisomerases [18].
2.1.4 Enzymatic inactivation or modification of antibiotics
In this case, the mechanism of action could be by enzymatic hydrolysis [19] or 
modification of chemical groups by transfer or addition of different chemical com-
pounds [14]. The classic example of a hydrolytic enzyme is the beta-lactamase, which 
hydrolyzes the beta-lactam ring, a common structural element in penicillins, cepha-
losporins, carbapenems, and monobactams [20]. Four classes of beta-lactamases have 
been described: the classes A, C, and D have a serine hydrolase activity; in contrast, 
class B has a metalloenzyme activity [21]. Another example of this type of resistance 
is provided by the enzymes erythromycin esterases EreA and EreB. These enzymes 
hydrolyze the macrolactone rings of macrolides such as erythromycin. It should be 
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noted that EreB enzyme confers resistance to almost all members of the macrolide 
class, with the exception of telithromycin, a semisynthetic erythromycin derivative, 
which belongs to a new class of antibiotics called ketolides [22]. In contrast, the EreA 
enzyme does not hydrolyze azithromycin and also telithromycin [23].
The modification of antibiotics includes the modification of some element of their 
structure, which is essential in the union with the bacteria target diminishing its affin-
ity. This mechanism involves the addition or transfer of groups such as N-acetyl, phos-
phoryl, O-nucleoside, O-ribosyl, and O-glycoside. Unlike hydrolysis, this modification 
does not destroy the essential structures of the antibiotic but obstructs the interaction of 
the antimicrobial with its target. An example of this mechanism occurs for polycationic 
antibiotics such as aminoglycosides, which act between the ionic bonds of the amino 
and hydroxyl groups of the antibiotics and the 16S rRNA region of the A site of the bac-
terial ribosome, deteriorating the translation mechanism. The enzymes responsible for 
the modification of the aminoglycosides are the aminoglycoside phosphotransferases 
(APH) and nucleotidyltransferases (ANT) that modify the hydroxyl groups and the 
aminoglycoside acetyltransferases (AAC) which modify the amino groups, changing 
the size, structure, and electronic properties of the antibiotic [24].
2.2 Genetic mobile elements transfer or acquired resistance mechanisms
Once the bacterial cell acquires some degree of antibiotic resistance by an intrin-
sic mechanism that implies DNA modification, it can transfer the gene or genes 
encoding for the resistance marker to the offspring (vertical transfer) or to a differ-
ent specie or genus (horizontal transfer) [25]. The gene resistance can be acquired 
by genetic mobile elements such as plasmids, transposons, or integrons [19].
The vertical transfer or vertical evolution occurs when a spontaneous mutation 
in the bacterial chromosome confers resistance to some members of the bacterial 
population. Once the resistance genes have arisen, they are transferred to the prog-
eny of the bacteria during DNA replication [6]. When the bacterial genes that con-
fer resistance to antibiotics are mobile, because they are contained within plasmids 
or are flanked by sequences recognized by some DNA transposition enzymes, they 
can be transferred between bacteria of a different taxonomic and ecological group. 
Some genetic mobile elements are plasmids, transposons, integrases, and genetic 
cassettes; in general this mechanism is called horizontal transfer gene [19, 26].
2.2.1 Plasmids
In bacterial cells, there are circular portions of extrachromosomal DNA that 
improve the survival characteristics of bacteria. This genetic information could 
be dispensable when it is no longer necessary to contend with the specific stress 
to which it imparts protection. Plasmids are self-replicating, given that they do so 
independently of chromosomal DNA replication. When plasmids contain anti-
biotic resistance genes, they are called plasmids R, and they can be transferred 
between bacteria of the same or different genera. Plasmids can be transferred to 
another bacterial cell by mechanisms called transformation or conjugation [19]. 
Transformation involves the acquisition of free DNA available in the medium. For 
this process the recipient bacteria must be in a competitive state; and the translo-
cated DNA must be stabilized, either by integration into the host receptor genome 
or by recircularization (in the case of plasmid DNA) [27]. In contrast, conjugation 
involves the transfer of DNA through a multistep process that requires cell-to-
cell contact, via cell surface pili or adhesins [28]. The conjugative machinery 
is encoded by genes in plasmids or by integrative conjugative elements in the 
chromosome [29].
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2.2.2 Transposons
These are already known as jumping genes. These are short chains of DNA that 
jump from chromosome to plasmid or vice versa. DNA transfer can occur between 
bacterial chromosome, plasmids, and bacteriophages. The most salient feature of 
transposons is that DNA acquired is easily integrated into the host chromosome or 
plasmids. Unlike plasmids, jumping genes are not self-replicating, and they must be 
kept within a self-replicating structure to replicate them [19].
2.2.3 Integrons and cassette system
Both of them provide a simple mechanism for the acquisition of new genes. The 
DNA acquisition implies a single event of a site-specific recombination that causes 
the integration or removal of a single gene or a group of antibiotic resistance genes 
called cassette [30]. The integrons have certain components which allow a site-spe-
cific recombination system that recognizes and captures mobile genes. An integron 
includes a gene that codes for an integrase (Intl) and a site of specific recombination 
(attI) [31]. The sequences of the integrase enzymes allow integron classification in 
different classes (I–III) [32].
Genetic cassettes are small mobile elements that include a short sequence of 57 
to 141 bp that are a specific recombination site. Cassettes can exist as free circular 
DNA molecules, and frequently they do not contain a promoter [30]. The lack of the 
promoter and the recombination sites make the recognition of the cassettes by Intl 
and Int13 and also by integrases encoded in the integrons possible. The integration 
of the cassettes to the integron structure allows the cassette genes’ transcription 
from the characteristic integron promoter called Pant [30].
The dangerous feature of the transfer of antibiotic-resistant genes by trans-
posons, integrons, or cassettes is the possibility that the bacterial receptor could 
acquire several classes of antibiotic resistance genes in a single event. A summary 
of the resistance to the different antibiotic classes, obtained by the intrinsic and 
acquired mechanisms, can be found in Table 1.
Antibiotic class/
antibiotics
Mode of action Mechanism of resistance
Beta-lactam [56]
Penicillins*
Penicillin G and V 
Cloxacillin
Ampicillin
Carbenicillin
Cephalosporins*
Cephaloridine
Cephalexin
Cefuroxime
Moxalactam
Ceftiofur
Cefoperazone
Cefepime
Inhibitors
Beta-lactamase*
Clavulanate
Sulbactam
Tazobactam
Carbapenems*
Imipenem/cilastatin
Aztreonam
Act as suicide 
substrates for 
penicillin-binding 
proteins (PBP) 
(transpeptidases)
They inhibit cell 
wall biosynthesis, 
specifically the 
peptidoglycan 
structure
Acquired
• Plasmids
• Transposons
• Integrons
(blaTEM-1, blaNDM-1, blaKPC, bla SHV, blaCTX-M, 
AmpC, blaVIM, blaOXA, and blaIMI genes) [57]
Intrinsic
• Bacterial flow pumps (RND, ABC, and 233 
transporter)
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Antibiotic class/
antibiotics
Mode of action Mechanism of resistance
Monobactams
[56, 58]
Aminoglycosides*
Streptomycin
Kanamycin
Neomycin
Gentamicin
Spectinomycin
Inhibits the synthesis 
of proteins by 
binding to the 
ribosomal 30S 
subunit
Intrinsic
• Bacterial flow pumps (MexXY and ABC 
transporter)
• Enzymatic modification (bla KPC gene)
• Ribosomal point mutation (rrs gene)
Diaminopyrimidines 
[56]
Trimethoprim
They inhibit 
DNA replication 
by binding to 
dihydrofolate 
reductase, an enzyme 
involved in the 
metabolism of folic 
acid
Acquired
• Transposon Tn7 (dhfrI gene) [59]
Intrinsic
• Competitive inhibition of folic acid synthesis
Phenicols [56]
Chloramphenicol
Thiamphenicol
They bind to the 
peptidyl transferase 
(PTC) center of 
the 50S ribosomal 
subunit to inhibit 
the translation 
elongation stage
Intrinsic
• Target modification (cfr gen)
• Bacterial flow pumps of amphenicols (Cml 
transporter)
Fluoroquinolones 
[60]
Enrofloxacin
Danofloxacin
Marbofloxacin
They inhibit 
DNA synthesis by 
topoisomerases II 
and IV
Intrinsic
• Target modification (gyrA and parC genes)
• Bacterial flow pumps of amphenicols (AcrA 
transporter)
Glycopeptides [56]
Vancomycin
Teicoplanin
Streptogramins
Virginamycin
They inhibit the cell 
wall biosynthesis 
in Gram-positive 
bacteria. They block 
the binding of the 
substrate and the 
transglycosylases
Intrinsic
• Bacterial flow pumps of amphenicols (AcrF 
transporter)
Acquired
• Transposon Tn1546 (van gene) [61]
Lincosamides [56]
Lincomycin
Clindamycin
Pirlimycin
They prevent protein 
elongation during 
translation by 
causing premature 
dissociation of the 
tRNA, inhibiting 
the 50S ribosomal 
subunit
Intrinsic
• Ribosomal modification by methylation or mutation 
(erm and msr genes) [62]
• Bacterial flow pumps (ABC and MFS transporter)
• Drug inactivation (Lnu and Mph genes) [62]
Macrolides [56]
Erythromycin
Oleandomycin
Tylosin
Spiramycin
Tilmicosin
Nitroimidazoles [63]
Metronidazole
They inhibit the 
synthesis of DNA by 
oxidation. The nitro 
group is reduced to 
toxic radical species
Intrinsic
• Bacterial flow pumps (RND and BME transporter)
• Reductive activation by altering
• The metabolism of pyruvate (PFOR)
Acquired
• Chromosomal mutations or plasmids acquired (nim 
gen)
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3. Overview of resistant pathogens isolated from food
Fruits, vegetables, and foods from animal origin can be contaminated with 
antibiotic-resistant bacteria at any time in the food chain FAO [2]. There has 
been an increase in drug resistance in pathogens isolated from food for human 
consumption since 2000. Salmonella enterica and Escherichia coli isolates have been 
considered among the most important pathogens, because they can make zoonotic 
transfer of resistant genes [33]. However other pathogens, such as Vibrio spp., some 
species of Aeromonas, spores of Clostridium botulinum type F, or enteric bacteria 
such as Campylobacter, have been linked to gastrointestinal diseases in humans 
who have consumed foods of animal and marine origin. It has been reported that 
multidrug-resistant plasmids are easily transferred to Aeromonas salmonicida by  
E. coli [34, 35].
Salmonella is a pathogenic bacterium that cause a gastrointestinal disease called 
salmonellosis. In Latin America, Asia, and Africa, 200–500 cases of salmonellosis 
per 100,000 inhabitants per year have been documented, where the 95% of the 
infections come from the consumption of contaminated foods [36]. Worldwide, 
it was estimated that the infections caused by Salmonella enterica are above 93.8 
million cases with 155,000 deaths per year [37].
Salmonella enterica is one of the most frequently isolated foodborne pathogens 
from different kinds of food. In the United States, between 11 and 20% of strains 
Antibiotic class/
antibiotics
Mode of action Mechanism of resistance
Peptides [64]
Polymyxin B
Colistin
They displace the 
Mg+2 and Ca+2 
ions and interact 
electrostatically 
with the 
lipopolysaccharides 
(LPS) of the external 
Gram-negative cell 
membranes
Intrinsic
• Reduction of specific proteins of the membrane and 
LPS
• Lipid modifications
Rifamycins [65]
Rifampicin
They stop 
transcription by 
interacting with the 
β subunit of RNA 
polymerase (RNAP)
Intrinsic
• Point mutations in the rifampicin-binding region of 
the β subunit of RNAP (rpoB gene)
• Bacterial flow pumps (VceB and Acr transporter) 
[56]
Sulfonamides [59]
Sulfanilamide
Sulfadiazine
Sulfatiazole
They act as 
competitive 
inhibitors of DHPS; 
they block the folate 
biosynthesis in the 
bacterial cell
Acquired
• Integrons (sul1 gene)
• Plasmids (IncQ class: sul2 gene)
Tetracyclines [66]
Doxycycline
Minocycline
Oxytetracycline
They block the access 
of the tRNA to the 
ribosome by binding 
to the 30S ribosomal 
subunit
Intrinsic
• Bacterial flow pumps (SMR, RND, or ABC 
transporter)
• Ribosomal modification
• Enzyme inhibition
(coded by different classes of tet, otr, and tcr genes)
*The subclasses of the class of beta-lactam
Table 1. 
Modes of action to different classes of antibiotics and their mechanisms of resistance.
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isolated from animals destined to human consumption were resistant to more 
than five different antibiotics [38]. Other studies mention that 82% of the isolates 
in strains from food are resistant to at least one antibiotic, associated with high 
resistance levels to tetracycline, streptomycin, sulfamethoxazole, and ampicillin 
[38]. In Latin American countries, the average of Salmonella resistant isolates is 
dependent on the region and analyzed food. In Brazil in a study conducted in a 
salami processing line, a 3.7% resistance to 1 antibiotic and 11.1% resistance to 3 or 
more antibiotics out of a total of 54 isolates have been reported [39]. In contrast, 
in a study conducted in pork carcasses, 147 out of 155 Salmonella strains isolated 
(94.85%) were resistant to at least one or more antibiotics [40].
Escherichia coli is one of the most widespread microorganisms in nature, and it is 
a member of the normal intestinal flora of many organisms, including humans. In 
a study conducted in Havana, Cuba, 74 E. coli-resistant strains were isolated from 
foods involved in foodborne diseases (ETA). Among foods with the highest CFU of 
E. coli serogroups identified, there were soy yogurt (14.3% of isolates), pork steak 
(11.9%), chicken hash (11.9%), cheese (9.5%), ham (9.5%), and beef hash (7.1%). 
Resistance to ampicillin was present in 36.4% of the isolates, and some isolates were 
also resistant to streptomycin, sulfamethoxazole, and tetracycline [41]. In America, 
Eastern Mediterranean, Africa, Southeast Asia, and the Western Pacific regions, an 
increased resistance to third-generation cephalosporins and fluoroquinolones into 
E. coli isolates has been reported [42].
On the other hand, studies conducted in dairy products have shown that 73.3% 
(33/45) of the E. coli strains isolated were susceptible to all antibiotics tested and 
24.4% (11/45) showed resistance to ampicillin. The phylogenetic analysis of the 
E. coli isolates resulted in grouping into two phylogroups, A and B1, which have a 
higher frequency of resistance genes than those that were grouped in B2 and D. It is 
worth to notice that E. coli isolates in this study that belonged to phylogroup A and 
B1 were commensal strains with few or no virulence factors [43]. These results sug-
gest that the food chain is the vehicle for the transfer of resistant genes, and it has 
been suggested that E. coli strains present in food are the original carrier of many 
mechanisms of antibiotic resistance in the intestinal microbiota of humans.
Studies conducted in different food classes have isolated other bacterial genera 
different to Salmonella enterica and E. coli. One of the most studied is Staphylococcus 
aureus, which causes staphylococcal poisoning. Strains of S. aureus have been 
studied in the last decades because they show resistance to methicillin. The analyses 
done in 282 S. aureus strains isolated from food and manipulators showed that 56.1% 
of the strains were resistant to one or more antimicrobials [44].
Another bacterial genus of health importance is Mycobacterium bovis. In the 
United States, outbreaks by M. bovis have been associated with the consumption 
of contaminated food. In 2007, 203 samples of cheese imported from Mexico were 
collected at the California customs office. Of the samples collected, 4.9% tested 
positive for Mycobacterium genus, with drug susceptibility test to streptomycin, 
isoniazid, rifampicin, ethambutol, and pyrazinamide, showing that they were sus-
ceptible to all the antibiotics tested except pyrazinamide [45]. In contrast, in Japan, 
58 M. bovis strain isolates from dairy cattle reported 7 strains resistant to the fluo-
roquinolones enrofloxacin, orbifloxacin, and danofloxacin. The fluoroquinolone 
resistance was associated with the mutation to quinolone resistance-determining 
regions of gyrA and parC genes (QRDR). The strains that showed no fluoroquino-
lone resistance phenotype did not present mutations [46].
Listeria, Shigella, and Campylobacter are other bacterial genera that have been 
isolated from foods and have shown antibiotic resistance. Listeria monocytogenes 
strains isolated from cheese have shown resistance to streptomycin, kanamycin, 
cephalothin, and tetracycline [47]. The analysis of 152 Shigella strains isolated 
Pathogenic Bacteria
10
from various foods that caused outbreaks of shigellosis in Brazil showed that 
several strains were resistant to streptomycin (88.6%), followed by ampicillin 
(84.6%) and sulfamethoxazole/trimethoprim (80.5%). The resistant strains 
were grouped into 73 patterns, where pattern A (resistance to ampicillin, sulfa-
methoxazole/trimethoprim, tetracycline, streptomycin, and chloramphenicol 
and intermediate resistance to kanamycin) grouped the highest number of 
isolates (n = 36) [48]. In Malaysia, Campylobacter spp. was reported with a 
prevalence of 17.4%, from a total of 340 cattle samples. Campylobacter isolates 
showed resistant to tetracycline (76.9%) and ampicillin (69.2%), while resistance 
to chloramphenicol was low (7.6%) [49].
Even in farms of goldfish (Carassius auratus), 70 strains of bacterial genera such 
as Aeromonas hydrophila, Vibrio fluvialis, and V. furnissii have been identified, with 
45% of the isolates being resistant to 6 of the 14 antibiotics tested; 100% of the 
strains were resistant to cephalothin, 94% to ampicillin, 89% to chloramphenicol, 
88% to tetracycline, 85.3% to nitrofurantoin, 61.3% to carbenicillin, and 65.3% to 
kanamycin. Twenty three percent of the isolates presented sensitivity to amikacin, 
trimethoprim, cefotaxime, netilmicin, pefloxacin, and gentamicin. Only one strain, 
A. hydrophila, showed resistance to all antibiotics tested. Twenty strains generated 
resistance to 7 different antibiotics, and 67 of the 70 strains generated resistance to 
more than 1 antibiotic [35].
As we can see in this overview, the resistance of the different bacterial genera 
isolated in a great diversity of foods is alarming, since many of these bacterial 
genera are the cause of many foodborne diseases. The diseases produced by these 
resistant pathogenic bacteria are difficult to treat, being able to provoke death in 
some patients.
4.  Economic implications/economic impact of the resistant pathogens in 
food
As we previously mentioned, the resistance occurs when the antibiotics used 
for the control of bacterial diseases are no longer optimal for their elimination. The 
most common routes to get infected with pathogenic bacteria are air, direct contact 
with sick people, or consumption of contaminated water or food. Pathogenic 
bacteria can be spread through sick people and contaminated fruits, vegetables, or 
animals that are intended for consumption. Antimicrobial resistance is a risk factor 
and complication of the disease, being difficult to treat infections, and it could be 
eventually lead to death [50]. In 2019, 700,000 deaths worldwide can be attributed 
to antimicrobial resistance, and the figure would rise to 35 million in 35 years, due 
to the lack of treatments to cure diseases caused by resistant pathogens; the esti-
mated cost for the treatment of these persons will be 100 billion dollars [51, 52].
Morbidity and mortality increase when the administration of effective treat-
ments to counteract infections caused by resistant pathogens is delayed. The 
duration of the disease and hospitalization of patients with infections by resistant 
pathogens have an economic impact, since there are extra procedures for the treat-
ment of the disease, the antibiotics that could be administered usually are more 
expensive than the ones used as first line, and also there are long hospitalization 
stays. The economic impact for the patient is due to the loss of productivity for 
taking care of themselves or a family member [50]. It is highlighted that 63.5% of 
infections are acquired in hospitals and that the groups with the highest incidence 
are under 1 year or over 65 years old [51, 52].
In Europe and the United States, more than 50,000 people die every year from 
infections with drug-resistant pathogens, while in India it is estimated that close to 
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60,000 newborns die due to resistant infections. There are at least 700,000 deaths 
every year caused by resistant microorganism that generate diseases such as bacte-
rial infections, malaria, HIV/AIDS, or tuberculosis [53]. The Centers for Disease 
Control and Prevention estimated that 2 million patients will be treated each year 
for resistant bacteria, of which 23,000 die [54]. In United States, it was estimated 
that there are an average of 1400 sick people with infection caused by resistant 
microorganisms, with a medical cost per patient estimated in $18,588 to $29,069 
US dollars with a mortality rate of 6.5%. In the European Union, the cost for loss 
of productivity due to an illness originated by resistant bacteria is estimated in 1.5 
billion € per year [55].
It is evident that the problem of bacterial resistance has reached great impact 
not only in the health of the population but also on its economy. For this reason, it 
is necessary to undertake actions that help in stopping the acquisition of the genetic 
elements that promote antibiotic resistance. Without doubt, the implementation 
of government laws that avoid the excessive use of antibiotics in livestock and fish 
farming could help to hinder the problem. Also the use of alternative molecules 
to antibiotics for the prevention of diseases in animals and improvement of the 
hygiene and vaccination measures in the farming collection and food processes 
would help to stop the problem of bacterial resistance. It has been proven that coun-
tries that have implemented control measures in the use of antibiotics in animals for 
human consumption and their products reduce up to 39% resistant bacteria. Not 
less important is the implementation of control measures in hospitals and clinics as 
well as generation of awareness in the population to avoid the overprescription of 
antibiotics, elements that all together can make a difference.
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